SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193805-22-001089
Filing Date
2022-07-11
Accepted
2022-07-11 16:05:47
Documents
1
Period of Report
2022-07-05

Document Format Files

Seq Description Document Type Size
1 e621828_3-toernsen.html 3  
1 e621828_3-toernsen.xml 3 1509
  Complete submission text file 0001193805-22-001089.txt   2997
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Issuer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address
Toernsen Monika Maria (Reporting) CIK: 0001873385 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36201 | Film No.: 221077016